Rapamycin insensitive regulation of 4E-BP1 has been described only recently by other groups e.g. in glioma cells, myoblasts and acute myeloid leukemia when comparing effects of rapamycin and NVP-BEZ235 treatment [45], [46], [47]. The gene discussed is EIF4EBP1; the disease is acute myeloid leukemia.